Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sleep apnea device producer Inspire Medical raises $14.5mm in Series C financing

Executive Summary

TGap Ventures has joined the investor syndicate for Inspire Medical Systems Inc. (mild neurostimulation implants for the treatment of obstructive sleep apnea), which completed a $14.5mm Series C financing. Returning shareholders including Medtronic, Kleiner Perkins Caufield & Byers, US Venture Partners, Synergy Life Science Partners, and GDN Holdings also participated. The money will support the Inspire upper airway stimulation system. Funds will specifically be used for clinical trial patient follow-up (patient recruitment and device implants were recently completed in the STAR multi-center trial); US regulatory filings; and commercial expansion in Europe, where the device received the CE Mark in 2010.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies